NORTHBOROUGH, Mass. , March 4, 2025 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to present at the 37th Annual ROTH Conference on Monday, March 17, 2025, to be held at The Laguna Cliffs Marriott in Dana Point, CA.
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2025 Results Conference Call March 4, 2025 1:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer Sean Capazorio - Group Chief Financial Officer Sibongakonke Nkosi Good morning. A very warm welcome to everyone joining us in person, online for Aspen's 2025 Interim Results Presentation.
MANVEL, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the final opportunity to build a new home in its Pomona - Aspen Collection community in Manvel, Texas. Only three homes, including one home that is move-in ready, remain available in this exclusive gated community within the Pomona master plan. The Sales Center is open at 4706 Mulberry Shrubs Lane in Manvel.
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Medical Penlight Market Size, Share & Trends Analysis Report By Type (Consumables, Equipment), By Light Output (Oncology, Cardiovascular Diseases), By Usability (Disposable, Reusable), By End-use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering. The global medical penlight market size was estimated at USD 279.7 million in 2024 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven significantly by the product's utility in diagnosing and assessing eye and ear conditions. According to a WHO report from August 2023, approximately 2.2 billion individuals experience distance vision impairment. Out of this group, vision impairment in at least 1 billion cases could have been prevented or remains untreated. Refractive errors and cataracts are identified as the primary causes of vision impairment and blindness worldwide. Medical professionals rely on penlights for their compact size, ease of use, and focused illumination, which are crucial in conducting detailed examinations of these sensitive areas. In ophthalmology, penlights are indispensable tools for examining the pupils, assessing pupil reactions to light, and detecting abnormalities such as irregularities in pupil size or shape, which can indicate neurological or ocular health issues. They are also crucial in assessing eye movements and conducting basic visual acuity tests, aiding in the diagnosis of conditions such as strabismus or nystagmus. The increasing prevalence of eye and ear disorders, coupled with advancements in penlight technology, is driving market growth. Manufacturers are innovating with features such as LED illumination for brighter and more efficient light output, ergonomic designs for comfortable handling during prolonged use, and enhanced durability for reliability in clinical environments. These advancements not only improve diagnostic accuracy but also streamline workflow efficiency in healthcare settings. In addition, otolaryngology (ENT), medical penlights are used for examining the ear canal, tympanic membrane, and assessing hearing conditions. They help ENT specialists to visualize abnormalities, foreign objects, and signs of infection or inflammation within the ear. Worldwide, the incidence of ENT conditions such as laryngitis, tonsillitis, sinusitis, and hearing loss is increasing. According to the World Health Organization (WHO), over 10% of the global population currently experiences varying degrees of hearing loss, a figure projected to approach nearly 2 billion by 2050. Penlights equipped with otoscopic attachments further enhance their utility by enabling magnified views and facilitating detailed inspections of the ear's internal structures. This capability is crucial for diagnosing conditions such as otitis media, ear wax buildup, and tympanic membrane perforations. Furthermore, the emphasis on preventive healthcare and early diagnosis is further boosting the demand in the medical penlights market. Routine screenings and examinations using penlights help in identifying eye and ear conditions at their early stages, enabling timely interventions and improving patient outcomes. As healthcare facilities continue to prioritize patient care and diagnostic accuracy, the role of medical penlights in supporting comprehensive eye and ear health assessments is expected to expand, driving continued market growth in the coming years. Global Medical Penlight Market Report Segmentation This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the medical penlights market report on the basis of type, light output, usability, end use and region.
Elliott Investment Management has a $1.5 billion stake in Aspen Technology, and the activist disagrees with a tender offer from Emerson Electric.
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Aspen Group, Inc. ("AGI") (OTCQB: ASPU), an education technology holding company, today announced that Aspen University (AU) has received notification of its renewal of accreditation from the Distance Education Accrediting Commission (DEAC), which is listed by the U.S. Department of Education as a recognized accrediting agency and recognized by the Council for Higher Education Accreditation (CHEA). The commission granted accreditation renewal to AU for five years through January 2029, the maximum accreditation period permitted by DEAC.